Yangyang Qiu - Publications

Evaluation of the Efficacy and Safety of Single-Needle Radiofrequency in Patients With Facial Sebaceous Hyperplasia: A Retrospective Study.

Journal: Journal of cosmetic dermatology

Published: April 06, 2025

miRSNP rs188493331: A key player in genetic control of microRNA-induced pathway activation in hypertrophic scars and keloids.

Journal: Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)

Published: February 16, 2024

Transition from secukinumab to adalimumab in COVID-19-induced psoriasis flare-up treatment: A case report.

Journal: Clinical case reports

Published: July 19, 2023

Penicillamine-induced degenerative dermopathy in a patient with Wilson's disease.

Journal: The Australasian journal of dermatology

Published: October 22, 2022

Centrifugal lipodystrophy on a spectrum with lupus erythematosus panniculitis in children and efficacy and safety of hydroxychloroquine: A clinicopathological study.

Journal: Dermatologic therapy

Published: February 28, 2022

Functional consequences of a rare missense BARD1 c.403G>A germline mutation identified in a triple-negative breast cancer patient.

Journal: Breast cancer research : BCR

Published: September 18, 2020

Pharmacokinetics of extended-release ivermectin microspheres after oral administration to healthy pigs.

Journal: Journal of veterinary pharmacology and therapeutics

Published: January 21, 2020

RNA-binding motif protein 43 (RBM43) suppresses hepatocellular carcinoma progression through modulation of cyclin B1 expression.

Journal: Oncogene

Published: January 18, 2020

PARP12 (ARTD12) suppresses hepatocellular carcinoma metastasis through interacting with FHL2 and regulating its stability.

Journal: Cell death & disease

Published: February 05, 2018